Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlative Study of Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome

NCT06676033 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT06676033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06676033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlative Study of Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 18, 2025
Completion date
July 1, 2027
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, chronic lymphocytic, richter syndrome